SOX2 and ovarian carcinoma: Conversely, through the analysis of MDAH-2774 and SKOV3 ovarian cell lines and The Cancer Genome Atlas (TCGA) data sets, Belotte et al. determined that SOX2 amplification in ovarian cancer leads to improved survival outcomes via a novel p53-dependent mechanism [198].